Keith Wharton

Keith Wharton

Company: Ultivue

Job title: VP Medical Director


Keith is a board-certified anatomic pathologist with diverse achievements in research and drug/diagnostic development.  Leading Ultivue’s Assay Services Laboratory, he brings expertise in investigative pathology, multiplex microscopy and imaging, and digital pathology to our customers striving to realize the promise of personalized medicine.  Most recently he was Senior Medical Director of Leica Biosystems, and prior to that he led and supported R&D, toxicology, biomarker, and clinical study teams in multiple therapeutic areas at Novartis and Biogen.

He earned a BS in Chemical Engineering from the University of Arizona, and MD and PhD in Molecular Biology from UCLA, where he discovered the molecular basis of DNA recognition by bHLH-PAS transcription factors.  Following residency and postdoc at Stanford, his lab at UT Southwestern characterized the Naked cuticle (Nkd) gene family as feedback regulators of Wnt-beta catenin signaling.


Panel + Q&A: Reaching New Heights by Working Together: How Abcam, Ultivue & Targos Builds Robust Partnership Chain & Support with Pharma from Clinical Trials Through to IVD 12:35 pm

How our commitment to the highest standards in immune-oncology, cancer and neuroscience diagnostics adds value to your work We understand your specific needs and our robust partnership process can help you rapidly advance the key stages of your mIHC from analytical validation to demonstration of clinical utility and all the way through to IVD application…Read more

day: Abcam Webinar Agenda

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.